Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide plus dexamethasone for cerebral oedema symptoms in recurrent or progressive high-grade glioma
ACTRN12615001072505Phase 2Terminated
- Sponsor
- The University of Sydney
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in glioma and cerebral edema comparing Acetazolamide + dexamethasone with Placebo + dexamethasone (2 arms). Primary endpoint: Composite dexamethasone reduction with neurological stability. Started Jul 2016; status: terminated.
02
Drugs
acetazolamide
03
Conditions
gliomacerebral edema
Beyond the preview
Go deeper on ACTRN12615001072505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001072505.